Funding Outside the Box: Alternative Financing Strategies for Startups

About this session

Biotech startups face unique challenges in securing the capital needed to drive innovation and growth. Traditional venture capital isn’t the only option—this panel dives into alternative financing strategies tailored to the biotech industry, including venture debt, royalty financing, private equity, and more. Hear from industry leaders and experienced founders as they share insights on how these models work, when to use them, and how to maximize their impact.

Speakers

• NO

  Nnenna Ohaka

  Partnering & Investment Reporter · BioXconomy

  Moderator

• AL

  Andrew Logerfo

  VP · HealthCare Royalty

  Panelist

• JM

  Joey Mason

  Venture Partner · Claret Capital Partners

  Panelist

• DW

  Dimitrios Weedon

  Managing Director · OrbiMed

  Panelist